Angiotensin-converting enzyme inhibitors for stroke prevention - Is there HOPE for PROGRESS after LIFE?

被引：19
作者：
Hankey, GJ
机构：
[1] Royal Perth Hosp, Dept Neurol, Perth, WA 6001, Australia
[2] Univ Western Australia, Dept Med, Perth, WA, Australia
来源：
STROKE | 2003年 / 34卷 / 02期
关键词：
angiotensin II; angiotensin converting enzyme inhibitors; risk factors; stroke prevention;
D O I：
10.1161/01.STR.0000054261.97525.4B
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：354 / 356
页数：3
相关论文
共 19 条
[1]  
BOSCH J, 2002, BRIT MED J, V324, P1
[2]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[3]   ESSENTIAL HYPERTENSION - RENIN AND ALDOSTERONE, HEART ATTACK AND STROKE [J].
BRUNNER, HR ;
BUHLER, FR ;
BARD, RH ;
BAER, L ;
GOODWIN, FT ;
NEWTON, MA ;
KRAKOFF, LR ;
LARAGH, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (09) :441-+
[4]  
Cohn J N, 2000, Heart Dis, V2, pS2
[5]   Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003
[6]   The renin angiotensin system as a risk factor for coronary artery disease. [J].
Farmer J.A. ;
Torre-Amione G. .
Current Atherosclerosis Reports, 2001, 3 (2) :117-124
[7]  
HANSSON L, 2002, INT HYP SOC EUR HYP
[8]   Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].
Lewis, EJ ;
Hunsicker, LG ;
Clarke, WR ;
Berl, T ;
Pohl, MA ;
Lewis, JB ;
Ritz, E ;
Atkins, RC ;
Rohde, R ;
Raz, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860
[9]   EMERGING ROLE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN CARDIAC AND VASCULAR PROTECTION [J].
LONN, EM ;
YUSUF, S ;
JHA, P ;
MONTAGUE, TJ ;
TEO, KK ;
BENEDICT, CR ;
PITT, B .
CIRCULATION, 1994, 90 (04) :2056-2069
[10]   Genetic profiling versus drug rotation in the optimisation of anti hypertensive treatment [J].
Mackenzie, IS ;
Brown, MJ .
CLINICAL MEDICINE, 2002, 2 (05) :465-473
12